Genetic Signatures to increase European Market presence at ECCMID 2013

Genetic Signatures will increase its European Market presence at the 23rd European Congress of Clinical Microbiology and Infectious Diseases, which will be held in Berlin from 27 to 30 April 2013.

Genetic Signatures will showcase the latest products in their EasyScreen range for the detection of infectious disease including kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis, including toxigenic and hypervirulent C. difficile, direct from faeces. Delegates will have an opportunity at ECCMID to meet with the new Europe based company representatives.

Dr Douglas Millar, Genetic Signatures’ Chief Research Scientist will also present posters outlining data on the EasyScreenproducts in development including meningitis, mycobacterium and STI detection kits.

Visit Genetic Signatures at Booth 523 for more information.